| Hilary Garlick, | |
|
1111 Washington Ave Ste 220, Golden, CO 80401-1162 | |
| (720) 441-2410 | |
| Not Available |
| Full Name | Hilary Garlick |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1111 Washington Ave Ste 220, Golden, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700356581 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | CSW.09925609 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hilary Garlick, 1111 Washington Ave Ste 220, Golden, CO 80401-1162 Ph: (720) 441-2410 | Hilary Garlick, 1111 Washington Ave Ste 220, Golden, CO 80401-1162 Ph: (720) 441-2410 |
News Archive
Gender-specific group therapy is effective for treating depressed women with Type 2 diabetes, according to a study published in the latest issue of the Annals of Behavioral Medicine and funded by the National Institute of Nursing Research.
Helix BioPharma today announced that it has received approval from Sweden's drug regulatory authority, the Medical Products Agency (MPA), to conduct a Phase II clinical trial of Topical Interferon Alpha-2b in patients with ano-genital warts (condylomata acuminata), who are positive for infection with the human papilloma virus (HPV).
Celator Pharmaceuticals today announced that it has expanded its research agreement with Cephalon, Inc.. The research agreement provides for the utilization of Celator's proprietary technology in an ongoing drug development and life-cycle management program at Cephalon.
Researchers used electricity on certain regions in the brain of a patient with chronic, severe facial pain to release an opiate-like substance that's considered one of the body's most powerful painkillers.
Halozyme Therapeutics, Inc. today announced the commencement of a Phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered with its proprietary rHuPH20 (PH20) hyaluronidase enzyme compared to each of the analogs alone. This randomized, three-way cross-over design, euglycemic clamp study will compare the postprandial pharmacokinetics (PK) and glucodynamics (GD) of the insulin analogs.
› Verified 6 days ago
Lauren Raissa Jensen, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5942 Culebra Ct, Golden, CO 80403 Phone: 720-791-2368 | |
Lindsey Feola, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 17301 W Colfax Ave, Golden, CO 80401 Phone: 719-200-8023 | |
Barbara Jean Middleton, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 22212 Chippewa Ln, Golden, CO 80401 Phone: 303-946-5003 Fax: 303-557-6240 | |
Ruth Lucia Settak, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 17301 W. Colfax Ave., Ste 200, Golden, CO 80401 Phone: 303-525-0901 | |
Kaye Cantwell, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24771 Westridge Rd, Golden, CO 80403 Phone: 303-875-2012 | |
Mr. Charles Erskine Pitte, M.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2221 East St, Golden, CO 80401 Phone: 303-271-3415 Fax: 303-431-4131 | |
Kathryn Marquard, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 710 10th St Ste 220, Golden, CO 80401 Phone: 708-740-0136 |